Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Efficacy and Non-inferiority, With Two Capsaicin Topic Treatments, for the Moderate to Severe Pain in Diabetic Neuropathy.

NCT05029297 is registered in ClinicalTrials.gov with Arafarma Group, S.A. as lead sponsor.

NCT NCT05029297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05029297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Efficacy and Non-inferiority, With Two Capsaicin Topic Treatments, for the Moderate to Severe Pain in Diabetic Neuropathy.
Lead sponsor
Arafarma Group, S.A.
Phase
Phase 3
Overall status
Completed
Start date
November 4, 2010
Completion date
October 23, 2018
Enrollment
161 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful